DGIdb - RITODRINE Drug Record

RITODRINE chembl:CHEMBL83063 Approved

Alternate Names:

DU-21220
RITODRINE

Drug Info:

FDA Approval	Approved before 1982
Drug Class	small molecule
Drug Indications	Tocolytic Agents
Year of Approval	approved before 1982
Drug Class	tocolytic agents

(1 More Sources)

Publications:

Baek MY et al., 2017, Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients., Eur J Clin Pharmacol
Bianchetti et al., 1990, In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon., Br. J. Pharmacol.
Schwarz et al., 2003, Preterm labour: an overview of current and emerging therapeutics., Curr. Med. Chem.
Lye et al., 1992, Failure of ritodrine to prevent preterm labor in the sheep., Am. J. Obstet. Gynecol.
Tanaka et al., 2001, Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence., J. Med. Chem.
Lenselink et al., 1994, Cardiovascular teratogenicity of terbutaline and ritodrine in the chick embryo., Am. J. Obstet. Gynecol.
Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.

RITODRINE ADRB2

Interaction Score: 2.31

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
1976401 12871140 1332478 11311067 8059831 11752352

Sources:
TdgClinicalTrial TEND PharmGKB TTD
RITODRINE CACNA1C

Interaction Score: 1.88

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
28391406

Sources:
PharmGKB

TEND: RITODRINE
- Version: 01-August-2011
Alternate Names:

RITODRINE Primary Drug Name

Drug Info:

Drug Class tocolytic agents

Year of Approval approved before 1982

Publications:
TdgClinicalTrial: RITODRINE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications Tocolytic Agents

Drug Class small molecule

FDA Approval Approved before 1982

Publications:
PharmGKB: ritodrine
- Version: 18-August-2020
Alternate Names:

Drug Info:

Publications:

Baek MY et al., 2017, Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients., Eur J Clin Pharmacol
TTD: Ritodrine
- Version: 2020.06.01
Alternate Names:

D00LFB TTD Drug ID

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL83063
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:

Trial Name	-
Novel drug target	Established target

RITODRINE Drug Record

RITODRINE chembl:CHEMBL83063 Approved

Alternate Names:

Drug Info:

Publications:

RITODRINE ADRB2

Interaction Types & Directionality: agonist (activating)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 1976401 12871140 1332478 11311067 8059831 11752352

Sources: TdgClinicalTrial TEND PharmGKB TTD

RITODRINE CACNA1C

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 28391406

Sources: PharmGKB

TEND: RITODRINE

Alternate Names: RITODRINE Primary Drug Name

Drug Info: Drug Class tocolytic agents Year of Approval approved before 1982

Publications:

TdgClinicalTrial: RITODRINE

Alternate Names:

Drug Info: Drug Indications Tocolytic Agents Drug Class small molecule FDA Approval Approved before 1982

Publications:

PharmGKB: ritodrine

Alternate Names:

Drug Info:

Publications: Baek MY et al., 2017, Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients., Eur J Clin Pharmacol

TTD: Ritodrine

Alternate Names: D00LFB TTD Drug ID

Drug Info:

Publications:

ChemblDrugs: chembl:CHEMBL83063

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
1976401 12871140 1332478 11311067 8059831 11752352

Sources:
TdgClinicalTrial TEND PharmGKB TTD

Interaction Types & Directionality:

n/a

PMIDs:
28391406

Sources:
PharmGKB

Alternate Names:

RITODRINE Primary Drug Name

Drug Info:

Drug Class tocolytic agents

Year of Approval approved before 1982

Drug Info:

Drug Indications Tocolytic Agents

Drug Class small molecule

FDA Approval Approved before 1982

Publications:

Baek MY et al., 2017, Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients., Eur J Clin Pharmacol

Alternate Names:

D00LFB TTD Drug ID